Начало・Списък с акции・Insulet Corp

Insulet Corp

Затворен

СекторЗдравеопазване

138.27 4.45

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

126.5

Максимум

165.98

Ключови измерители
By Trading Economics
Приходи	-11M 91M
Продажби	-22M 762M
P/E Средно за сектора	39.65 68.51
EPS	1.42
Марж на печалбата	11.96
Служители	5,400
EBITDA	-23M 154M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+22.86% upside

Дивиденти
By Acuity
Следващи печалби	5.11.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-117M 12B
Предишно отваряне	133.82
Предишно затваряне	138.27

Insulet Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

5.08.2026 г., 23:46 ч. UTC

Insulet Corp. shares traded lower in after-market hours, reflecting routine activity and cautious market sentiment amid disappointing private sector employment data.

4.08.2026 г., 23:56 ч. UTC

Insulet Corp shares are lower in after-market hours, showing little change since Tuesday's close amid a lack of specific company news.

3.08.2026 г., 19:36 ч. UTC

Correlated Moves

Insulet Corp's shares are higher today, supported by a positive trend in the medical devices sector. The stock remains above its 20-day moving average.

31.07.2026 г., 20:06 ч. UTC

News

Insulet Corp shares are declining amid a securities class action lawsuit alleging misrepresentations about the safety of its Omnipod products.

29.07.2026 г., 18:43 ч. UTC

Insulet Corp shares are higher, driven by gains in the Health Care Equipment sub-sector. The stock remains well above its 20-day moving average.

28.07.2026 г., 19:06 ч. UTC

Correlated Moves

Insulet Corp shares are trading higher, benefiting from a significant rise in the Health Care Equipment sub-sector and ongoing momentum above their 20-day moving average.

27.07.2026 г., 20:06 ч. UTC

Insulet Corp shares are higher today, reflecting broader market trends despite an earlier pullback from a session high. No specific news was identified.

24.07.2026 г., 22:26 ч. UTC

Insulet Corp shares are lower in after-market hours, following a decline from earlier session lows. No specific company news was identified to explain the movement.

22.07.2026 г., 20:01 ч. UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities fraud related to safety claims about its Omnipod products.

20.07.2026 г., 18:36 ч. UTC

News

Insulet Corp is gaining today after being identified as a healthcare stock likely to deliver sustainable market-beating returns, despite ongoing legal challenges.

Сравнение с други в отрасъла

Ценова промяна

Insulet Corp Прогноза

Ценова цел

By TipRanks

22.86% нагоре

12-месечна прогноза

Среден 204.95 USD 22.86%

Висок 275 USD

Нисък 144 USD

Според 22 анализатори от Wall Street, предложили 12-месечна ценова цел за Insulet Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

22 ratings

Купи

Задържане

Продай

Според 22 анализатори, дали борсови рейтинги на Insulet Corp през последните 3 месеца.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.